204
U N I T 2
Integrative Body Functions
13. Makaryus AN, McFarlane SI. Diabetes insipidus: Diagnosis and
treatment of a complex disease.
Cleve Clin J Med.
2006;73(1):65–71.
14. Ditorgi N, Napoli F, Allegri AEM. Diabetes insidus—diagnosis
and management.
Horm Res Paediatr.
2012;77:69–84.
15. Sands JM, Bichet DG. Nephrogenic diabetes insipidus.
Ann
Intern Med.
2006;144:186–194.
16. Behan LA, Phillips J, Thompson LT, et al. Neuroendocrine
disorders after traumatic brain injury.
J Neurol Neurosurg
Psychiatry.
2008;79:753–759.
17. Alexander MP, Farag YM, Mattal BV, et al. Lithium toxicity: a
double-edged sword.
Kidney Int.
2008;73(2):233–237.
18. Robertson GL. Regulation of arginine vasopressin in
the syndrome of inappropriate antidiuresis.
Am J Med.
2006;119:S36–S42.
19. Hannon MJ, Thompson CJ. The syndrome of inappropriate
antidiuretic hormone: prevalence, causes, and consequences.
Eur
J Endocrinol.
2010;162:S5–S12.
20. Sherlock M, Thompson CJ. The syndrome of inappropriate
antidiuretic hormone: current and future management option.
Eur J Endocrinol.
2010;162:S13–S18.
21. Adrogue HJ, Madias NE. Hyponatremia.
N Engl J Med.
2000;343:1581–1589.
22. Adrogue HJ, Madias NE. The challenge of hyponatremia.
J Am
Society Nephrol.
2012;23:1140–1148.
23. Vaidya C, Warren H, Freda BJ. Management of hyponatremia:
Providing treatment and avoiding harm.
Cleve Clin J Med.
2010;27(10):715–726.
24. Mount DB. The brain in hyonatremia: both culprit and victim.
Semin Nephrol.
2009;29(3):196–215.
25. Murase T, Sugimura Y, Takefuji S, et al. Mechanisms and therapy
of osmotic demyelination.
Am J Med.
2006;119(7A):S69–S73.
26. Adrogue HJ, Madias NE. Hypernatremia.
N Engl J Med.
2000;342:1493–1499.
27. Sam R, Feizi I. Understanding hypernatremia.
Am J Nephrol.
2012;36:97–104.
28. Al-Absi A, Gosmanova EO, Wall BM. The clinical
approach to chronic hypernatremia.
Am J Kidney Dis.
2012;60(6):1032–1038.
29. Rao MC. Oral rehydration therapy.
Annl Rev Physiol.
2004;66:385–417.
30. Palmer BF, Dubose TD. Disorders of potassium metabolism.
In: Scheir RW, ed.
Renal and Electrolyte Disorders
. 7th ed.
Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams &
Wilkins; 2010:137–165.
31. Schaefer T, Wolford RW. Disorders of potassium.
Emerg Med
Clin North Am.
2005;23:723–747.
32. Palmer BF. A physiologic-based approach to the evaluation
of a patient with hypokalemia.
Am J Kidney Dis.
2010;56:1184–1190.
33. Pepin J, Shields C. Advances in diagnosis and management of
hypokalemic and hyperkalemic emergencies.
Emerg Med Pract.
2012;14(2):1–18.
34. Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and
management of hyperkalemia.
Pediatr Nephrol.
2011;26:377–384.
35. Moe SM. Disorders involving calcium, phosphorus, and
magnesium.
Prim Care.
2008;35(2):215–237.
36. Popovtzer MM. Disorders of calcium, phosphorus, vitamin D,
and parathyroid hormone activity. In: Schrier RW, ed.
Renal and
Electrolyte Disorders
. 7th ed. Philadelphia, PA: Wolters Kluwer
Health | Lippincott Williams & Wilkins; 2010:166–228.
37. Peacock M. Calcium metabolism in health and disease.
Clin J
Am Soc Nephrol.
2010;5:S23–S30.
38. Fong J, Khan A. Hypocalcemia.
Can Fam Physician.
2012;58:158–162.
39. Liamis G, Millionis H, Elisaf M. A review of drug-induced
hypocalcemia.
J Bone Miner Metab.
2009;27:635–642.
40. Assadi F. Hypercalcemia: an evidence-based approach to clinical
cases.
Iran J Kidney Dis.
2009;3(2):71–79.
41. Stewart AF. Hypercalcemia associated with cancer.
N Engl J Med.
2005;353(4):373–379.
42. Medaroov BL. Milk-alkali syndrome.
Mayo Clin Proc.
2009;84(8):
261–267.
43. Ziegler R. Hypercalcemia crisis.
J Am Soc Nephrol.
2001;12:
S3–S9.
44. Leaf DE, Wolf M. A physiologic-based approach to evaluation
of a patient with hyperphosphatemia.
Am J Kidney Dis.
2013;61(2):330–336.
45. Felsenfeld AJ, Levine BS. Approach to treatment of
hypophosphatemia.
Am J Kidney Dis.
2012;60(4):655–661.
46. Hruska KA, Mathew S, Lund R, et al. Hyperphosphatemia of
chronic kidney disease.
Kidney Int.
2008;74(2):148–157.
47. Hsu HJ, Wu MS. Extreme hyperphosphaemia and hypocalcemic
coma associated with phosphate enema.
Intern Med.
2008;47(7):643–648.
48. Musso CG. Magnesium metabolism in health and disease.
Int
Urol Nephrol.
2009;41:357–362.
49. Guerrera ME, Volpe S, Mao JJ. Therapeutic uses of magnesium.
Am Fam Physician.
2009;80(2):157–162.
50. Speigel DM. Normal and abnormal magnesium metabolism.
In: Schrier RW, ed.
Renal and Electrolyte Disorders
. 7th ed.
Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams &
Wilkins; 2010:229–250.
51. Gums JG. Magnesium in cardiovascular and other disorders.
Am
J Health Syst Pharm.
2004;61:1569–1576.
52. Fogleman CD. Magnesium sulfate and other anticonvulsants
for women with preeclampsia.
Am Fam Physician.
2011;83(11):1269–1271.
53. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia.
Rev Endocr Metab Disord.
2003;4:195–206.
54. Martin KJ, Gonzalez EA, Slatopolsky E. Clincial consequences
and management of hypomagnesemia.
J Am Soc Nephrol.
2009;20:2291–2295.
55. Hoom EJ, van der Hoek J, de Mart RA, et al. A series of proton
pump inhibitor-induced hypomagnesemia.
Am J Kidney Dis.
2010;56(1):112–116.
56. Shoback D. Primary hypoparathyroidism.
N Engl J Med.
2008;359(4):391–403.
57. Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in
the adult: Epidemiology, diagnosis, pathophysiology, target organ
involvement, treatment, and challenges for the future.
J Bone
Mineral Res.
2011;26(10):2317–2337.
58. Mark SJ. Hypoparathyroid and hyperparathyroid disorders.
N Engl J Med.
2000;343(25):1863–1875.
59. Taniegra ED. Hyperparathyroidism.
Am Family Physician.
2004;69:333–339.
60. Ahmad R, Hammond JM. Primary, secondary, and tertiary
hyperparathyroidism.
Otolaryngol Clin North Am.
2004;17:703–713.
61. Marcocci C., Cetani F. Hyperparathyroidism.
N Engl J Med.
2011;365(25):2389–2397.
62. Adrogue HE, Adrogue HJ. Acid–base physiology.
Respir Care.
2001;46:328–341.
63. Koeppen BM. The kidney and acid–base balance.
Adv Physiol
Educ.
2009;33:275–281.
64. Whittier WL, Rutecki GW. Primer on clinical acid–base problem
solving.
Dis Mon.
2004;50:117–162.
65. Ralman S, Kaehny W, Shapiro JI. Pathogenesis of metabolic
acidosis and alkalosis. In: Schrier RW, ed.
Renal and Electrolyte
Disorders
. 7th ed. Philadelphia, PA: Wolters Kluwer Health |
Lippincott Williams & Wilkins; 2010:86–121.
66. Kraut JA, Madas NE. Metabolic acidosis: Pathology, diagnosis,
and management.
Nat Rev Nephrol.
2010;6:274–285.
